Press release
Intravenous Immunoglobulin Market Generating Revenue of USD 24.13 Billion by 2032, At a Booming 7.50% Growth Rate
Intravenous Immunoglobulin Market
๐๐ก๐๐ญ ๐ข๐ฌ ๐๐ง๐ญ๐ซ๐๐ฏ๐๐ง๐จ๐ฎ๐ฌ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง?
Intravenous immunoglobulin are therapies assembled for the syndicate of immunoglobulins for plasma for innumerable fit donors. Immunoglobulins are rendered by the immune system of fit people for the motive of battling contaminations. Dissimilar to several medications established by rheumatologists, IVIG does not escalate the probability of infections. IVIG operates in varied ways to prohibit the body from ambushing itself and reduce many kinds of redness in the body. It is considered secure for usage in the course of pregnancy and breastfeeding.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ญ๐ก ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐จ๐ฌ๐ฉ๐๐๐ญ๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ
The market is expanding due to companies diligently advancing and commercializing IVG therapies resulting in a broad gamut of commodities. The market is also impacted by administrative schemes, repayment structures, and regional agitation. The IVIG market is anticipated to flourish due to growing healthcare disbursement, a surge in the elderly population, and augmenting off-label usage of IVIG.
Moreover, the growing existence of immunodeficiency illnesses can be credited to several aspects, such as enhanced diagnostic approach, growing consciousness, and superior comprehension of these conditions among healthcare experts.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐จ๐ง ๐๐๐๐ฉ ๐๐ข๐ฏ๐
The market is splintered and is expected to observe contention due to many player's existence. Some of the prominent players operating in the intravenous immunoglobulin market include:
โข Baxter International Inc.
โข BDI Pharma Inc.
โข Biotest AG
โข China Biologics Products Inc.
โข CSL Behring
โข Grifols SA
โข Kedrion Biopharma
โข LFB Biotechnologies
โข Octapharma AG
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐ฉ๐ฎ๐ซ๐๐ก๐๐ฌ๐: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/inquire-before-buying
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
โข North America makes up the majority of the market. This is primarily because of a growing aggregate of cancer patients and the existence of critical players such as Baxter International Inc. Productive drugs are growing established in the market.
โข Throughout the projection period, it is expected that the Asia Pacific market will grow at a faster CAGR. This results from a sizeable population involving excessively populated nations such as India and China.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
Intravenous immunoglobulin, Component Outlook (Revenue - USD Billion, 2019 - 2032)
โข IGG
โข IGA
โข IGM
โข IGE
โข IGD
Intravenous immunoglobulin, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
โข Intravenous
โข Subcutaneous
Intravenous immunoglobulin, Application Outlook (Revenue - USD Billion, 2019 - 2032)
โข Hypogammaglobulinemia
โข Chronic Inflammatory demyelinating polyneuropathy (CIDP)
โข Immunodeficiency diseases
โข Myasthenia Gravis
โข Multifocal motor neuropathy
โข Idiopathic thrombocytopenic purpura (ITP)
โข Inflammatory myopathies
โข Specific antibody deficiency
โข Guillain-Barre syndrome
Intravenous immunoglobulin, End-Users Outlook (Revenue - USD Billion, 2019 - 2032)
โข Hospitals
โข Homecare
โข Specialty Clinics
Intravenous immunoglobulin, Distribution channels Outlook (Revenue - USD Billion, 2019 - 2032)
โข Hospital Pharmacy
โข Retail Pharmacy
โข Online Pharmacies
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ญ๐ก๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฐ: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market
๐๐ง๐ญ๐ซ๐๐ฏ๐๐ง๐จ๐ฎ๐ฌ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข During the forecast period, the IgG segment is expected to be the largest. IgG has been extensively researched in clinical trials, which has resulted in its widespread use and acceptance in the medical field. These studies have demonstrated IgG's efficacy and safety in treating various autoimmune disorders, neurological conditions, and other immune-related diseases.
โข The immunodeficiency diseases segment held the largest market share in 2022. Immunodeficiency diseases can be categorized into two types: primary (inherited) and secondary (acquired). Primary immunodeficiencies are typically genetic and present from birth, while secondary immunodeficiencies can develop later in life due to factors such as infections, medications, or medical treatments.
โข Hospitals accounted for the highest share in 2022. Hospital pharmacies monitor patients receiving IVIG therapy, collaborate with healthcare professionals to track patient progress, and report any adverse events or reactions to regulatory bodies.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐๐'๐ฌ ๐๐ฑ๐ญ๐๐ง๐ฌ๐ข๐ฏ๐ ๐จ๐ง๐ ๐จ๐ข๐ง๐ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐จ๐ฆ๐๐ข๐ง:
Biotechnology Market: https://www.polarismarketresearch.com/industry-analysis/biotechnology-market
E-Pharmacy Market: https://www.polarismarketresearch.com/industry-analysis/e-pharma-market
Cell Culture Market: https://www.polarismarketresearch.com/industry-analysis/cell-culture-market
Virus Filtration Market: https://www.polarismarketresearch.com/industry-analysis/virus-filtration-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Market Generating Revenue of USD 24.13 Billion by 2032, At a Booming 7.50% Growth Rate here
News-ID: 3664286 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Industrial Metaverse Market Size Expected to Reach USD 315.53 Billion By 2032 Wi โฆ
The growing interest in digital twins has been an influential factor in the increasing growth and revenue of the industrial metaverse industry. Based on component analysis, the hardware segment accounted for the highest share. By region, North America spearheaded the market.
๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐ซ๐๐ฌ๐ฌ๐๐ฌ:
โข The global industrial metaverse market was valued at USD 22.93 billion in 2023 and is expected to grow to USD 315.53 billion by 2032.
โข The market is anticipatedโฆ
Vector Database Market Set to Achieve USD 10,409.89 Million By 2032, Growing at โฆ
๐๐๐๐ญ๐จ๐ซ ๐๐๐ญ๐๐๐๐ฌ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฏ๐๐๐ญ๐จ๐ซ ๐๐๐ญ๐๐๐๐ฌ๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐,๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐๐,๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide vector database market. Comprehensive analyses of sales volume, price, revenue, market share, and important companiesโฆ
Beta-Glucan Market to See Significant Growth by 2032 - Detailed Analysis and Ins โฆ
Polaris Market Research's latest report, titled "Beta-Glucan Market," 2024-2032. The report covers key success factors, market performance, risk factors, project costs and economics, expected ROI, and profit margins. The global market was valued at USD 621.98 million in 2023 and is expected to grow to USD 1,285.40 million by 2032 at a CAGR of 8.4% during the forecast period.
๐๐ก๐๐ญ ๐ข๐ฌ ๐๐๐ญ๐-๐๐ฅ๐ฎ๐๐๐ง?
There are two prominent groupings of dietary fiber. Soluble fiberโฆ
Cheese Powder Market to Reach USD 9.90 billion by 2032 | PMR
๐๐ก๐ ๐๐ก๐๐๐ฌ๐ ๐ฉ๐จ๐ฐ๐๐๐ซ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ข๐ณ๐ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐. ๐๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐๐ฑ๐ก๐ข๐๐ข๐ญ๐ข๐ง๐ ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐๐ง๐ง๐ฎ๐๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ (๐๐๐๐) ๐จ๐ ๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
Dehydrated fresh cheeses, known as cheese powder, are now widely used in urban households and the global food processing industry. Dehydration leads to a decrease in fresh cheeses' water content while maintainingโฆ
More Releases for Intravenous
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.
Key Finding
The global Intravenous (IV) Solution market and is expected to reach USDโฆ
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market isโฆ
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products.
Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075
Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illnessโฆ
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term โimmunoglobulinโ refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit fromโฆ
Peripheral Intravenous Catheter Market
New research report offers a comprehensive analysis of the โPeripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021โThe main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market.
Request to view Sample Report @ https://www.mrrse.com/sample/2827
Peripheral intravenous catheter is a sophisticated medical device widely used toโฆ
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence toโฆ
